AbbVie Inc banner

Intrinsic Value

The intrinsic value of AbbVie Inc (4AB) under the Base Case is EUR per share. Compared with the current market price of 270.4 EUR, the stock appears .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

4AB Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when 4AB is below its intrinsic value
Today Hidden ·
4AB Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to 4AB

Fundamental Analysis

What AbbVie Does

Biotechnology Health Care

AbbVie is a pharmaceutical company that develops and sells prescription medicines. Its business is built around branded drugs for conditions such as immune disorders, cancer, eye disease, and other serious illnesses. It also works on research and development to create new treatments and support its long-term drug portfolio.

Headquarters
United States of America US
Employees
57 000
IPO date
Jan 2, 2013
Read the full company overview
View Company Overview

AbbVie has a wide economic moat

No Moat Narrow Wide

Patents prevent rivals from copying AbbVie’s protected medicines and competing mainly on price. Protection across several treatments helps the company defend its profits without relying on a single drug.

Read the full moat analysis
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

AbbVie insiders are selling less than usual

Insider trading · Last trade on Aug 14, 2026

Sold $10.7m 3 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Continue 4AB Research

Decided on AbbVie? Get an email when 4AB reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one 4AB stock?

The intrinsic value for AbbVie Inc (4AB) under the Base Case is EUR.

Is 4AB stock undervalued or overvalued?

Compared with the current market price of 270.4 EUR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top